Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

SIMPLE SUMMARY: Systemic inflammation is associated with an increased aggressiveness of breast cancer and can contribute to a decreased activity of neoadjuvant treatments. Biomarkers of systemic inflammation are easily obtained from routine blood counts and are highly cost-effective, having great po...

Descripción completa

Detalles Bibliográficos
Autores principales: Truffi, Marta, Sottotetti, Federico, Gafni, Nadav, Albasini, Sara, Piccotti, Francesca, Morasso, Carlo, Tibollo, Valentina, Mocchi, Michela, Zanella, Valentina, Corsi, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658892/
https://www.ncbi.nlm.nih.gov/pubmed/36358706
http://dx.doi.org/10.3390/cancers14215287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658892/
https://www.ncbi.nlm.nih.gov/pubmed/36358706
http://dx.doi.org/10.3390/cancers14215287

Ejemplares similares